Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Amortizatization of Intangibles (2019 - 2026)

Usana Health Sciences (USNA) has disclosed Amortizatization of Intangibles for 7 consecutive years, with $1.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Amortizatization of Intangibles fell 17.19% to $1.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $7.3 million, a 5.98% decrease, with the full-year FY2024 number at $7.7 million, changed 0.04% from a year prior.
  • Amortizatization of Intangibles was $1.6 million for Q3 2025 at Usana Health Sciences, down from $1.9 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $2.7 million in Q1 2022 to a low of $1.6 million in Q3 2025.
  • A 5-year average of $2.0 million and a median of $1.9 million in 2023 define the central range for Amortizatization of Intangibles.
  • Peak YoY movement for Amortizatization of Intangibles: fell 26.81% in 2022, then increased 8.04% in 2023.
  • Usana Health Sciences' Amortizatization of Intangibles stood at $2.3 million in 2021, then fell by 13.24% to $2.0 million in 2022, then dropped by 0.05% to $2.0 million in 2023, then decreased by 3.78% to $1.9 million in 2024, then decreased by 12.57% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for USNA's Amortizatization of Intangibles are $1.6 million (Q3 2025), $1.9 million (Q2 2025), and $1.9 million (Q1 2025).